Professor Dame Lesley Jean Fallowfield DBE (born October 1949) [1] is a British cancer psychologist and a professor of psycho-oncology at the University of Sussex. The main outcomes of her research have been the establishment of assessment tools to measure quality of life in clinical trials of cancer patients and the design of educational programmes to improve oncologists' communication with their patients.
Fallowfield initially trained as a nurse at Guy's Hospital in London before studying a bachelor's degree in experimental psychology at the University of Sussex in 1980. [2] [3] She went on to complete a doctorate in psychophysics at Sussex and the University of Cambridge. [4] She had originally planned to pursue a career in visual science but the death of a friend from graft-versus-host disease secondary to a bone marrow transplant for acute myeloid leukaemia inspired her to focus on cancer. [3] [5] In 1984, she began working for the King's College London Clinical Trials Unit, [3] where she established assessment criteria to measure quality of life in trials of breast cancer. [2] These tools are in use worldwide as of 2016. [5]
Fallowfield received a grant from the Cancer Research Campaign in the late 1980s to research oncologists' communication skills and potential areas for improvement. She focused on the communications between doctors and their patients—particularly in communicating complex medical concepts, giving bad news, and recruiting patients to take part in clinical trials. This led her to design educational materials to enhance doctors' communication skills and to study the resulting effects on patients' health and wellbeing. [2] In 1990, she became the director of the Cancer Research Campaign Communication and Counselling Research Centre and a lecturer at the London Hospital Medical College. She was appointed the first professor of psycho-oncology in the United Kingdom by University College London in 1997. [3]
In 2001, Fallowfield moved from UCL to the University of Sussex, [6] where she is a professor of psycho-oncology at Brighton and Sussex Medical School and the director of the University of Sussex Health Outcomes Research & Education in Cancer (SHORE-C) group. [4] Throughout her career she has authored over 450 articles, book chapters and textbooks. [7]
Fallowfield has two children. Her son is a hepatologist and her daughter is a paediatric nurse. [5] [6]
Surgical oncology is the branch of surgery applied to oncology; it focuses on the surgical management of tumors, especially cancerous tumors.
M. Krishnan Nair was an Indian oncologist. He was the founding director of the Regional Cancer Centre, Thiruvananthapuram, a director of the S.U.T. Institute of Oncology, and Trivandrum Cancer Center(TCC), part of SUT Royal Hospital in Thiruvananthapuram (Trivandrum) and a professor at the Amrita Institute of Medical Sciences & Research in Kochi. The Government of India awarded him the fourth highest civilian award of the Padma Shri, in 2001 for his contributions in the cancer care field.
The European Organisation for Research and Treatment of Cancer (EORTC) is a unique pan-European non-profit clinical cancer research organisation established in 1962 operating as an international association under Belgium law. It develops, conducts, coordinates and stimulates high-quality translational and clinical trial research to improve the survival and quality of life of cancer patients. This is achieved through the development of new drugs and other innovative approaches, and the testing of more effective therapeutic strategies, using currently approved drugs, surgery and/or radiotherapy in clinical trials conducted under the auspices of a vast network of clinical cancer researchers supported by 220 staff members based in Brussels. The EORTC has the expertise to conduct large and complex trials especially specific populations such as the older patient and rare tumours.
Psycho-oncology is an interdisciplinary field at the intersection of physical, psychological, social, and behavioral aspects of the cancer experience for both patients and caregivers. Also known as psychiatric oncology or psychosocial oncology, researchers and practitioners in the field are concerned with aspects of individuals' experience with cancer beyond medical treatment, and across the cancer trajectory, including at diagnosis, during treatment, transitioning to and throughout survivorship, and approaching the end-of-life. Founded by Jimmie Holland in 1977 via the incorporation of a psychiatric service within the Memorial Sloan Kettering Cancer Center in New York, the field has expanded drastically since and is now universally recognized as an integral component of quality cancer care. Cancer centers in major academic medical centers across the country now uniformly incorporate a psycho-oncology service into their clinical care, and provide infrastructure to support research efforts to advance knowledge in the field.
Dame Parveen June Kumar, is a British doctor who is currently Professor of Medicine and Education at Barts and The London School of Medicine and Dentistry. She worked in the NHS for over 40 years as a consultant gastroenterologist and physician at Barts and the London Hospitals and the Homerton University Hospital. She was the President of the British Medical Association in 2006, of the Royal Society of Medicine from 2010-2012, of the Medical Women's Federation from 2016-2018 and of the Royal Medical Benevolent Fund from 2013-2020. She was also Vice President of the Royal College of Physicians from 2003-2005. In addition, she was a founding non-executive director of the National Institute of Clinical Excellence, chaired the Medicines Commission UK until 2005, and also chaired the BUPA Foundation Charity for Research until 2013.
Pramod Kumar Julka, is an Indian cancer specialist (oncologist), medical educationist and writer, known for performing the first peripheral blood stem cell transplant following high dose chemotherapy in Metastatic Breast Cancer in India. He was honoured by the Government of India, in 2013, by bestowing on him the Padma Shri, the fourth highest civilian award, for his contributions to the fields of medicine and medical education. The American Society of Clinical Oncology (ASCO) has awarded him by bestowing on him the honorary membership.
Edith A. Pérez is a Puerto Rican hematologist-oncologist. She is the Serene M. and Frances C. Durling Professor of Medicine at the Mayo Clinic Alix School of Medicine.
Kathleen I. Pritchard, is the head of oncology at Sunnybrook Health Sciences Centre in Toronto, Canada, specializing in breast cancer therapies, and leading the clinical trials division of the centre. She has authored numerous studies on women's health, breast cancer, hormone replacement therapy, public health, and research methodology. According to Thomson Reuters, Pritchard was one of the most cited researchers in the world in 2014 and 2015.
The Association of Cancer Physicians (ACP) is a specialty association in the United Kingdom for medical oncologists. The ACP is recognised by the Royal College of Physicians and the Department of Health, and provides training and regular meetings for members.
Jimmie Coker Holland was a founder of the field of psycho-oncology. In 1977, she worked with two colleagues to establish a full-time psychiatric service at Memorial Sloan Kettering Cancer Center. The program was one of the first of its kind in cancer treatment, and trained its psychologists to specialize in issues specific to people with cancer.
Sandra M. Swain is an American oncologist, breast cancer specialist and clinical translational researcher. She is currently a professor of Medicine at the Georgetown University School of Medicine and the Associate Dean for Research Development at Georgetown University Medical Center (GUMC) and MedStar Health as well as an adjunct professor of Medicine at the F. Edward Hébert School of Medicine of the Uniformed Services University of Health Sciences. She is also a past President of the American Society of Clinical Oncology (ASCO), serving from 2012 through 2013.
Heather A. Wakelee is a professor of oncology at Stanford University Medical Center. Her research focuses on lung cancer.
Lea Baider, is a professor of medical psychology, and considered one of the founders of psycho-oncology. She is the director of psycho-oncology at the Sharsheret Institute of Oncology at the Hadassah Medical Center in Jerusalem. Baider is also a member of the Middle East Cancer Consortium. Baider runs workshops in psycho-oncology to expand the field.
Maryam Beheshti Lustberg is an American breast oncologist. She is the Director of The Breast Center at Smilow Cancer Hospital and Chief of Breast Medical Oncology at Yale Cancer Center. Lustberg previously served as the Medical Director of Supportive Care at Ohio State's Comprehensive Cancer Center and President-Elect of the Multinational Association of Supportive Care in Cancer. She is also an associate editor for the peer-reviewed medical journal covering oncology nursing with respect to cancer survivors called Journal of Cancer Survivorship.
Bhuvaneswari Ramaswamy is an American breast medical oncologist and hematologist. She serves as section chief of Breast Medical Oncology and as director of the Medical Oncology Fellowship Program in Breast Cancer for The Ohio State College of Medicine.
Pamela Lyn Kunz is an American oncologist. She is the leader of the Gastrointestinal Cancers Program at Yale Cancer Center and Smilow Cancer Hospital and director of GI Medical Oncology within the Section of Medical Oncology. She was formerly the director of the Stanford Neuroendocrine Tumor Program before leaving, in part due to gender harassment.
Allison Walsh Kurian is an American medical oncologist. She is a Professor of Medicine and Epidemiology & Population Health at Stanford University and an oncologist at the Stanford Cancer Institute.
Worta McCaskill-Stevens is an American physician-scientist and medical oncologist specialized in cancer disparities research, management of comorbidities within clinical trials, and molecular research for cancer prevention interventions. She is chief of the community oncology and prevention trials research group at the National Cancer Institute.
Elizabeth R. Plimack is an American medical oncologist. She is a professor in the Department of Hematology/Oncology and Chief of the Division of Genitourinary Medical Oncology at the Fox Chase Cancer Center. In these roles, she researches the treatment of genitourinary malignancies with a focus on bladder and kidney cancers.
Sophie Postel-Vinay is a French physician and scientist at the Institut Gustave Roussy where she has led an ATIP-Avenir team since 2018. She works on oncology and the development of new drugs and is an expert in early clinical trials. She was the 2019 winner of the Irène Joliot-Curie Prize in the “young woman scientist” category.